Immunization with autologous T cells enhances in vivo anti-tumor immune responses accompanied by up-regulation of GADD45beta (Q79853276)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Immunization with autologous T cells enhances in vivo anti-tumor immune responses accompanied by up-regulation of GADD45beta (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Li Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Fang Du

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Qi Cao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Huiming Sheng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Baihua Shen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yan Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yingna Diao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Jingwu Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ningli Li

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

702-712

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cr.7310083

26 December 2019

exact match

0 references

cites work

Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Escape from immune surveillance does not result in tolerance to tumor-associated antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Gene-based vaccines and immunotherapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Suppressor of Cytokine Signaling-1 Is Essential for Suppressing Dendritic Cell Activation and Systemic Autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Potent antitumour activity of a new class of tumour-specific killer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Turning on/off tumor-specific CTL response during progressive tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Immunocompetent cells and lymphocyte reactivity to mitogens in levamisole-treated brain tumor children.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Strategies of antigen-specific T-cell-based immunotherapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Prolongation of survival of rat cardiac allografts by T cell vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

T-cell vaccination: from basics to the clinic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Interferon beta induces T-helper 2 immune deviation in MS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Apoptosis, autophagy, and more

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Cell death induced by the Fas/Fas ligand pathway and its role in pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Functional avidity directs T-cell fate in autoreactive CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Linking JNK signaling to NF-kappaB: a key to survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Gadd45beta is important for perpetuating cognate and inflammatory signals in T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

GADD45beta/GADD45gamma and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNgamma production in T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

NF-kappaB-dependent regulation of the timing of activation-induced cell death of T lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Gadd45 beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310083

7 January 2021

Identifiers

DOI

10.1038/SJ.CR.7310083

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16826163%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference